At detection or over time, @entity157 ( @entity157 ) is multicentric in origin, against a background of chronic @entity99 at different stages. Orthotopic liver transplantation (OLT) is the only therapy able to definitely cure both diseases. When OLT is not feasible, all other options can be only palliative. Owing to the multicentricity, surgical resection may be one possible option at the initial detection in selected @entity1 , whereas percutaneous interventional techniques (percutaneous @entity1068 injection [ @entity8681 ], radiofrequency ablation [RFA], selected transcatheter arterial chemoembolization [TACE]) are the options more of tenused. The range of their indications is becoming wider. Although it is understood that partial resection assures the greatest local control, the survival rates after surgery are roughly comparable with those obtained with @entity8681 . The explanation for this result reflects a balance among the advantages and disadvantages of the two therapies. @entity8681 survival curves are better than curves of resected @entity1 who present with adverse prognostic factors, and this means that a better selection of the @entity1 for surgery is needed. An open question remains the choice among percutaneous techniques. In our department we currently use RFA in most @entity1 but consider @entity8681 and selected TACE complementary, and use them according to the features of the disease and the response.

Radiofrequency ablation, PEIT, and TACE for XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity8681 :: ('CHEBI:53231', 'Chemical') :: ['PEI'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'hepatocellular carcinoma'] @entity99 :: ('MESH:D056486', 'Disease') :: ['hepatic disease'] @entity1068 :: ('MESH:D000431', 'Chemical') :: ['ethanol']
@entity157 :: (MESH:D006528,Disease) :: ['hepatocellular carcinoma']
